WV MSSP 2016 Enhanced
Colleen Wagner
ACO Primary Contact
202-803-7979
Location
Location

Aledade West Virginia ACO, LLC
4550 Montgomery Ave, Ste 950N
Bethesda, MD 20814
 

ACO Participants ACO Participant in Joint Venture
ADVANCED FAMILY PRACTICE, PLLC N
Charleston Internal Medicine Inc N
Chesapeake Medical Center, PLLC N
CROSS LANES INTERNAL MEDICINE GROUP INC N
DUNBAR MEDICAL ASSOCIATES PLLC N
Family Health Associates of the Kanawha Valley PLLC N
Finbar Powderly N
Healthy Habits Wellness Ctr, Inc N
JOHN HOLLOWAY N
Kanawha Medical Center Inc N
MOUNTAIN STATE MEDICAL ASSOCIATES PLLC N
Mountain State Medicine and Rheumatology PLLC N
Patel Inc N
Prestige Primary Care Associates PLLC N
Spring Hill Primary Care Physicians PLLC N
Williamson Health & Wellness Center Inc N
WV Primary Care Inc N

First Name Last Name Member's Voting Power (Expressed as a percentage or number) Membership Type Practice Legal Business Name
Ghali Bacha 1 ACO Participant Representative Chesapeake Medical Center, PLLC
Julie DeTemple 1 ACO Participant Representative Family Health Associates of Kanawha Valley PLLC
Finbar Powderly 1 ACO Participant Representative Finbar G. Powderly MD
John Holloway 1 ACO Participant Representative John Holloway
Rohit Patel 1 ACO Participant Representative Patel Inc
Christopher Skaggs 1 ACO Participant Representative Spring Hill Primary Care Physicians PLLC
Ashish Sheth 1 ACO Participant Representative WV Primary Care Inc
John Lilly 1 ACO Participant Representative Dunbar Medical Associates PLLC
Thopsie Jagannath 1 ACO Participant Representative Kanawha Medical Center Inc
Reginald Triplett 1 ACO Participant Representative Mountain State Medicine and Rheumatology PLLC
Scott Moore 1 ACO Participant Representative Prestige Primary Care Associates PLLC
Jon Miller 1 ACO Participant Representative Health Habits Wellness Ctr, Inc
Vicki Johnson 1 ACO Participant Representative Williamson Health & Wellness Center Inc
Tom Bowden 1 ACO Participant Representative Charleston Internal Medicine Inc
Joseph Donzella 1 ACO Participant Representative Advanced Family Practice, PLLC
Kelli Dumm 1 ACO Participant Representative Mountain State Medical Associates PLLC
Arvind Viradia   ACO Participant Representative Cross Lanes Internal Medicine Group Inc
Colleen Wagner 1 Other Aledade, Inc.
John Wilshire 1 Medicare Beneficiary Representative N/A

  • Executive Director: Ms. Colleen Wanger
  • Medical Director: Dr. Jonathan Lilly
  • Compliance Officer: Ms. Sarah Chasson
  • Quality Assurance/Improvement Officer: Dr. Emily Maxson
  • Beneficiary Engagement Committee: Dr. Jonathan Lilly, Chair
  • Transitions of Care Committee: Dr. Franklin Moore, Chair
  • Compliance Committee: Dr. Jonathan Lilly
  • Evidence-Based Medicine Committee: Dr. Christopher Skaggs Chair
  • Networks of individual practices of ACO professionals

Second Agreement Period 

  • Performance Year 2021, $5,374,760
  • Performance Year 2020, $4,840,442
  • Performance Year 2019, $4,866,915

First Agreement Period

  • Performance Year 2019, $4,866,915
  • Performance Year 2018, $1,187,169
  • Performance Year 2017, $2,950,672
  • Performance Year 2016, $1,566,654

Note: Our ACO participated in multiple performance years during Calendar Year 2019. Shared savings/losses amount reported for Performance Year 2019 therefore represents net shared savings or losses across all performance years in 2019 and is shown under all agreement periods in which the ACO operated during Calendar Year 2019.

Second Agreement Period  

  • Performance Year 2021
    • Proportion invested in infrastructure: 10%
    • Proportion invested in redesigned care processes/resources: 40%
    • Proportion of distribution to ACO participants: 50%
  • Performance Year 2020
    • Proportion invested in infrastructure: 10%
    • Proportion invested in redesigned care processes/resources: 40%
    • Proportion of distribution to ACO participants: 50%
  • Performance Year 2019
    • Proportion invested in infrastructure: 10%
    • Proportion invested in redesigned care processes/resources: 40%
    • Proportion of distribution to ACO participants: 50%

First Agreement Period  

  • Performance Year 2019  
    • Proportion invested in infrastructure: 10%
    • Proportion invested in redesigned care processes/resources: 30%
    • Proportion of distribution to ACO participants: 60%
  • Performance Year 2018  
    • Proportion invested in infrastructure: 10%
    • Proportion invested in redesigned care processes/resources: 30%
    • Proportion of distribution to ACO participants: 60%
  • Performance Year 2017
    • Proportion invested in infrastructure: 10%
    • Proportion invested in redesigned care processes/resources: 30%
    • Proportion of distribution to ACO participants: 60%
  • Performance Year 2016
    • Proportion invested in infrastructure: 10%
    • Proportion invested in redesigned care processes/resources: 30%
    • Proportion of distribution to ACO participants: 60%

Note: Our ACO participated in multiple performance years during Calendar Year 2019. Distribution of shared savings reported for Performance Year 2019 therefore represents the distribution of the net shared savings across all performance years in 2019 and is shown under all agreement periods in which the ACO operated during Calendar Year 2019.

2021 CMS WEB INTERFACE QUALITY PERFORMANCE RESULTS:
Measure #
Measure Name
Rate
ACO Mean
Measure #: 1
Diabetes: Hemoglobin A1c (HbA1c) Poor Control2
12.62
12.46
Measure #: 134
Preventative Care and Screening: Screening for Depression and Follow-up Plan
89.52
74.38
Measure #: 236
Controlling High Blood Pressure
76.73
74.87
Measure #: 318
Falls: Screening for Future Fall Risk
92.77
87.03
Measure #: 110
Preventive Care and Screening: Influenza Immunization
78.11
80.52
Measure #: 226
Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention
95.52
80.97
Measure #: 113
Colorectal Cancer Screening
84.16
73.63
Measure #: 112
Breast Cancer Screening
73.37
75.11
Measure #: 438
Statin Therapy for the Prevention and Treatment of Cardiovascular Disease
78.35
84.24

Please note, the Quality ID #: 370 Depression Remission at 12 months quality measure is not included in public reporting due to low sample size.

For Previous Years’ Financial and Quality Performance Results, Please Visit data.cms.gov.

Payment Rule Waivers

Waiver for Payment for Telehealth Services:

  • Our ACO clinicians provide telehealth services using the flexibilities under 42 CFR § 425.612(f) and 42 CFR § 425.613.
Fraud and Abuse Waivers